Ledger.Open graph →
SEC Form D · filed August 13, 2014

Trimel Pharmaceuticals Corp

Offering
$2.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MISSISSAUGA, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Jeffrey L. Sherman · Mississauga, Ontario, CanadaDirectorRolf K. Reininghaus · Mississauga, Ontario, CanadaExec · DirectorKenneth G. Howling · Mississauga, Ontario, CanadaExecStephen K. Gregory · Mississauga, Ontario, CanadaDirectorTom Rossi · Mississauga, Ontario, CanadaExec · DirectorMatthew Hawkins · Mississauga, Ontario, CanadaExecRonald Lowy · Golden, COExecJohn D. Orcutt · Palo Alto, CAExec · DirectorThorsten Claus · Palo Alto, CADirectorJason Krikorian · Palo Alto, CADirectorTom Rossi · Buffalo, NYExec · DirectorMatthew Hawkins · Salt Lake City, UTExecMatthew K. Pfeffer · Mississauga, Ontario, CanadaExecIan K. Ihnatowycz · Mississauga, Ontario, CanadaDirectorD. L. Tyrell · Mississauga, Ontario, CanadaDirectorNathan Bryson · Mississauga, Ontario, CanadaExecJohn K. Friedrichsen · Mississauga, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗